Growth Metrics

Cellectis (CLLS) Leases (2019 - 2026)

Cellectis (CLLS) posted Leases of $20.5 million for Q1 2026, down 13.24% on a QoQ basis from $23.7 million in Q4 2025, and down 27.93% year-over-year from $28.5 million in Q1 2025.

Cellectis (CLLS) has 8 years of Leases data on file, last reported at $20.5 million in Q1 2026.

  • In Q1 2026, Leases fell 27.93% year-over-year to $20.5 million; the TTM figure through Mar 2026 stood at $20.5 million (down 27.93% YoY), while the FY2025 annual figure was $23.7 million, down 21.06% from the prior year.
  • Leases eased to $20.5 million in Q1 2026, from $23.7 million in the prior quarter.
  • Across five years, Leases topped out at $67.2 million in Q1 2022 and bottomed at $20.5 million in Q1 2026.
  • A 5-year average of $38.2 million and a median of $35.8 million in 2024 frame the typical range for Leases.
  • The widest YoY moves for Leases: up 5.6% in 2022, down 36.22% in 2022.
  • Year by year, Leases stood at $44.3 million in 2022, then decreased by 14.04% to $38.1 million in 2023, then dropped by 21.26% to $30.0 million in 2024, then retreated by 21.06% to $23.7 million in 2025, then dropped by 13.24% to $20.5 million in 2026.
  • The last three Leases figures came in at $20.5 million (Q1 2026), $23.7 million (Q4 2025), and $25.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 61,822.50
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 189.30 Mn
10 Cellectis 20.83 Bn 20.62 Bn - 20.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.53 Mn
Dec 31, 2025 23.66 Mn
Sep 30, 2025 25.51 Mn
Jun 30, 2025 27.38 Mn
Mar 31, 2025 28.48 Mn
Dec 31, 2024 29.97 Mn
Sep 30, 2024 32.23 Mn
Jun 30, 2024 33.67 Mn
Mar 31, 2024 35.79 Mn
Dec 31, 2023 38.06 Mn
Sep 30, 2023 39.15 Mn
Jun 30, 2023 41.46 Mn
Mar 31, 2023 43.44 Mn
Dec 31, 2022 44.28 Mn
Sep 30, 2022 58.11 Mn
Jun 30, 2022 61.09 Mn
Mar 31, 2022 67.23 Mn
Dec 31, 2021 69.42 Mn
Sep 30, 2021 71.90 Mn
Jun 30, 2021 74.05 Mn
Mar 31, 2021 71.21 Mn
Dec 31, 2020 73.85 Mn
Sep 30, 2020 64.31 Mn
Jun 30, 2020 63.67 Mn
Mar 31, 2020 47.81 Mn
Dec 31, 2019 45.61 Mn
Sep 30, 2019 46.39 Mn
Jun 30, 2019 47.88 Mn
Mar 31, 2019 36.79 Mn